Navexio serves as the exclusive distributor of Tempus genomic testing and Ambry Genetics hereditary cancer testing services across Canada. Through this partnership, Canadian healthcare providers and their patients can access the full suite of Tempus oncology testing with dedicated Canadian support, logistics coordination, and clinical guidance.

This collaboration ensures that Canadian oncologists and their patients benefit from the same cutting-edge genomic insights available to leading cancer centres worldwide.